Related Experiment Videos
Effectiveness of rimantadine prophylaxis of children within families
Insights
Rimantadine hydrochloride prophylaxis in children effectively prevented influenza A infections, significantly reducing illness and transmission within families during an H1N1 outbreak. This antiviral treatment showed good tolerability in pediatric participants.
Area of Science:
- Virology
- Epidemiology
- Pediatric Infectious Diseases
Background:
- Recent studies indicate children are primary vectors for introducing influenza into households.
- Understanding influenza transmission dynamics within families is crucial for public health interventions.
Purpose of the Study:
- To evaluate the prophylactic efficacy of rimantadine hydrochloride in children against influenza A transmission within family units.
- To assess the impact of pediatric rimantadine prophylaxis on both child and adult influenza infection rates.
Main Methods:
- A placebo-controlled, double-blind, randomized trial involving 145 volunteers across 35 families during an influenza A (H1N1) outbreak.
- Influenza infection was confirmed by positive viral throat culture or a fourfold increase in antibody titer.
- Clinical illness and adverse events were monitored in both the rimantadine and placebo groups.
Main Results:
- Children receiving rimantadine prophylaxis had a significantly lower incidence of influenza A infection (2.9%) compared to the placebo group (31.7%).
- No clinical illness with laboratory-confirmed influenza occurred in children treated with rimantadine, versus 17.0% in the placebo group.
- Adults in households with children on rimantadine prophylaxis showed a reduced rate of influenza A infection (8.8%) compared to those with children on placebo (19.0%).
Conclusions:
- Rimantadine hydrochloride prophylaxis in children is an effective strategy for preventing influenza A infection in pediatric populations.
- Pediatric rimantadine prophylaxis demonstrated a potential to reduce influenza A transmission to adults within the same household.
- Further research is warranted to fully elucidate the impact of childhood rimantadine prophylaxis on parental influenza A infection incidence.
Abstract:
With recent studies suggesting that children are the main introducers of influenza infections into families, we conducted a placebo-controlled, double-blind, randomized trial to study the prophylactic effectiveness of rimantadine hydrochloride in children on the transmission of influenza A infections within families. One hundred forty-five volunteers from 35 families completed this study during a naturally occurring outbreak of influenza A (H1N1) infection. Influenza infections, defined as a positive viral throat culture or a fourfold increase in antibody titer, occurred in 31.7% of children in the placebo group and 2.9% of children in the rimantadine group. Clinical illness with laboratory evidence of influenza infection occurred in 17.0% of children in the placebo group and 0% of children in the rimantadine group. Rimantadine was well tolerated by the children, with no significant difference in reported side effects between the placebo and rimantadine groups. Influenza A infection occurred in 19.0% of adults whose children were receiving a placebo and 8.8% of adults whose children were receiving rimantadine. On the basis of our study, rimantadine prophylaxis of children appears to be an effective method to prevent influenza A infection in children. Additional studies are needed to demonstrate the effects of rimantadine prophylaxis of children on the incidence of influenza A infection in their parents.